The role of stem cells in developing new drugs

DefiniGEN, a new spin-out company from the University of Cambridge, has been formed to supply hIPSC-derived cells to the drug discovery and regenerative medicine sectors. The company is based on the research of Dr. Ludovic Vallier, Dr. Tamir …

[Read the full article here]

Comments are closed.